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ABSTRACT 
 
An aneurysm is a balloon-like bulge in the wall of blood vessels, occurring in major arteries 
from the heart and brain. Biodegradable stent-assisted coiling is expected to be the ideal treatment 
of wide-neck complex aneurysms. A number of biodegradable stents are promising, but also with 
issues and/or several limitations to be addressed. From the design point of view, biodegradable 
stents are typically designed without structure optimization. The drawbacks of these stents often 
cause weaker mechanical properties than native arterial vessels. From the fabrication point of view, 
the conventional methods of the fabricating stent are time-consuming and expensive, and also lack 
precise control over the stent microstructure. As an emerging fabrication technique, dispensing-
based rapid prototyping (DBRP) allows for more accurate control over the scaffold microstructure, 
thus facilitating the fabrication of stents as designed. 
This thesis is aimed at developing methods for fabrication and optimal design of 
biodegradable stents for treating aneurysms. Firstly, a method was developed to fabricate 
biodegradable stents by using the DBRP technique. Then, a compression test was carried out to 
characterize the radial deformation of the stents fabricated. The results illustrated the stent with a 
zigzag structure has a higher radial stiffness than the one with a coil structure. On this basis, the 
stent with a zigzag structure was chosen to develop a finite element model for simulating the real 
compression tests. The result showed the finite element model of biodegradable stents is 
acceptable within a range of radial deformation around 20%. Furthermore, an optimization of the 
zigzag structure was performed with ANSYS DesignXplorer, and the results indicated that the 
total deformation could be decreased by 35% by optimizing the structure parameters, which would 
represent a significant advance of the radial stiffness of biodegradable stents. Finally, the 
optimized stent was used to investigate its deformation in a blood vessel. The deformation is found 
to be 0.25 mm in the simulation, and the rigidity of biodegradable stents is 7.22%, which is able 
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to support the blood vessel all. It is illustrated that the finite element analysis indeed helps in 
designing stents with new structures and therefore improved mechanical properties. 
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CHAPTER 1 Introduction 
 
1.1 Research Background and Motivation 
An aneurysm is a balloon-like bulge in the wall of blood vessels, occurring in major arteries 
from the heart (aortic aneurysm) and brain (cerebral aneurysm). Aortic aneurysms cause over 
13,000 deaths in America each year [1], and cerebral aneurysms contribute to approximately 
30,000 people suffering a rupture in America each year [2]. When an intracranial aneurysm 
ruptures, it may bleed into the subarachnoid space and result in a subarachnoid hemorrhage, with 
a mortality rate of 25% to 50% [2]. Endovascular treatment (EVT) by selective coiling is 
considered one of the main treatments for intracranial aneurysms. The efficacy of EVT is limited 
with respect to the treatment of wide-necked and/or large aneurysms and recanalization can occur 
after EVT. To circumvent these limitations, a number of new devices have been developed over 
the last decade. [3] Among them, self-expandable stents made from biodegradable material are 
promising, and can provide temporary scaffolds in the blood vessel.   
Over the past two decades, metallic stents have been considered the gold standard in terms 
of treatment of more complex intracranial aneurysms. Recently, biodegradable stents (BDS) have 
been emerging and demonstrating advantages over permanent metallic stents [4]. First, the option 
of BDS may alleviate patient concerns over permanent implants, especially with respect to the 
possibility of late stent thrombosis and in-stent stenosis [5]. Second, BDS can help to control drug 
release and can facilitate the reduction of in-stent neointimal formation and consequently minimize 
the circumstance of restenosis [6]. With the degradation of the stents, only is a healed arterial 
vessel left behind. Therefore, long-term clinical problems such as in-stent restenosis and late stent 
thrombosis could be solved [7].  
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1.2 Brief Review of the Related Studies 
Recently, the research on degradable biomaterials has become one of the most 
revolutionary studies at the forefront of biomaterials. This novel class of biomaterial is expected 
to serve as temporary implants, such as scaffolds and stents. The biodegradable stent is able to 
provide a temporary support to a blood vessel, and then to be dissolved progressively afterwards 
[7].  
Stack et al. at Duke University developed the first biodegradable stents and implanted them 
in animals [8]. A polymer monofilament of poly-L-lactic acid (PLLA) was used for this prototype 
stent, which could keep its radial strength for 1 month with up to 1000 mm Hg of crush pressure. 
It took 9 months for the stent to be almost completely degraded. Clinical results remained limited 
despite the presence of moderate neointimal growth, minimal thrombosis and a limited 
inflammatory response in early animal implants.  
The Igaki-Tamai stent, the first bioabsorbable stent, was implanted in humans. The Igaki-
Tamai stent is made of PLLA with a thickness of 170 µm with a zigzag helical coil pattern. 
However, the Igaki-Tamai stent lacked a drug coating, which limited its development. The study 
[9] shows the comparison of the results between the Igaki-Tamai and the metal stents. The Igaki-
Tamai stent achieved a high secondary patency rate after a year, but the modifications of stent 
characteristics are needed with the goal to decrease the restenosis rate during the reabsorption 
period.  
The leading effort in this area in the market is sponsored by Abbott Laboratories, which 
has been developing a new type of stent called Absorb.  Absorb is made of PLLA with a Poly (D-
L-lactide) (PDLLA) coating. The diameter of Absorb is from 2.5 mm to 3.5 mm, and the length is 
from 8mm to 28mm with the thickness of 150 µm strut in the form of zig-zag hoops. The Absorb 
stent is able to deliver drugs to reduce inflammatory reaction [10].  
  
 3 
 
1.3 Research Issues and Objectives 
Currently, there are a number of biodegradable polymeric stents that have shown some 
successes, but also, with issues and/or several limitations to be addressed. Most biodegradable 
stents are made with zigzag structures, but there is no optimal design method utilized, drawbacks 
of which often cause weaker mechanical properties compared to native arterial vessels and result 
in early recoil post implantation [11]. In addition, the conventional methods of fabricating stents 
are typical to braid monofilaments of biodegradable polymer into a tubular structure [12, 13], thus 
being time-consuming and expensive, and also lack precise control over the stent microstructure. 
Therefore, the conventional methods of fabricating stents result in poor repeatability and limit the 
design improvements that can be made. As an emerging fabrication technique, the dispensing-
based rapid prototyping (DBRP) allows for more accurate control over the scaffold microstructure, 
thus facilitating the fabrication of stents as designed [14, 15]. 
The present research is aimed at developing methods for fabrication and optimal design of 
biodegradable stents for the treatment of aneurysms. The central hypothesis of this research is that 
biodegradable stents can be fabricated with a well-controlled microstructure by means of the 
DBRP fabrication technique, thus providing appropriate mechanical properties for the treatment 
of aneurysms. 
 
The following specific objectives will be pursued in the present research. 
1. To develop a method to fabricate the biodegradable stents based on the DBRP techniques; 
2. To characterize radial stiffness of the biodegradable stents through compression tests; 
3. To model and simulate the compression test of biodegradable stents with Pro/Engineering and 
ANSYS Workbench software; 
4. To optimize the structure of biodegradable stents and to perform a simulation in order to 
investigate the deformation of biodegradable stents in blood vessels with ANSYS Workbench. 
 
1.4 Outline of the Thesis 
The remainder of this thesis is laid out in six chapters as follows:  
Chapter 2 presents a literature review on the structures, materials and fabrication 
techniques of biodegradable stents with their advantages and disadvantages discussed.  
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Chapter 3 presents a fabrication technique for designed biodegradable stents. This chapter 
presents the work towards Objective 1.  
Chapter 4 documents a study of compression test of biodegradable stents, which aims to 
achieve Objective 2. Particularly, this chapter includes design and procedure of experiments and 
discussion of the results.  
Chapter 5 presents the development of a parametric model for biodegradable stents and 
simulation results of compression tests based on the developed model. This chapter presents the 
work towards Objective 3. In particular, this chapter includes a comparison between the 
compression test and simulation results to verify the effectiveness of the developed model. 
Chapter 6 presents the study on optimizing the structure of biodegradable stents through 
the ANSYS DesignXplorer, which is a design optimization application that works under the 
ANSYS Workbench environment. Then, the deformation of the optimized stent in a blood vessel 
is examined. This chapter is to achieve the Objective 4.  
Chapter 7 presents the conclusions drawn from this research, followed by limitations and 
possible future work.   
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CHAPTER 2 Literature Review 
 
2.1 Introduction to the Development of Stents for Aneurysm Treatment 
An aneurysm is a balloon-like bulge in the wall of blood vessels, occurring in major arteries 
from the heart and brain. Coiling, one of the main treatments for intracranial aneurysms, is limited 
with the respect to the treatment of wide-necked and/or large aneurysms. Stent-assisted coiling 
(SAC) was introduced over 10 years to overcome this challenge [16]. The intracranial stents 
enabled the endovascular treatment of wide-neck complex aneurysms that cannot be coiled 
previously. The reason is that stents can prevent coil protrusion into the parent artery and provide 
a scaffold for endothelial growth and vessel wall healing [17]. It has been proven that SAC is an 
effective and safe approach through several studies since 1990s [18].  
Initially, stents were made of metals such as cobalt-chromium and 316L stainless steel. But 
some issues including stent thrombosis and in-stent restenosis (ISR) remains to be addressed. Stent 
thrombosis remains a major cause of death and morbidity after percutaneous interventions, while 
symptoms of ISR, such as asymptomatic angiographic narrowing and recurrent angina/ischemia, 
typically occur within 6 to 9 months following intervention [19]. In order to reduce the rate of 
thrombosis and restenosis, drug-eluting stents (DES) were introduced into clinical practice for the 
treatment of cardiovascular and cerebral artery disease. However, a limited amount of drug can be 
carried with the thin polymer coating, thus making it difficult to sustain high local drug 
concentration for a long period [20]. Due to limitations of bare metallic stents and DES mentioned 
above, biodegradable stents have the advantage of no longer being present as a foreign material in 
arteries with their degradation. The other significant advantage is that drugs can be incorporated 
within stents and then be released in a controlled manner. There has therefore been substantial 
interest and development in recent years in the field of biodegradable stents. 
 
2.2 Materials for Stents 
Biodegradable stents are commonly made from synthetic polymers, because of their broad 
range of properties [21]. Among them, the mechanical properties, mainly characterized by the 
radial stiffness, and biodegradability, are of significant importance and should be selected such 
that biodegradable stents are mechanically strong enough to avoid potential immediate recoil. 
Once the biodegradable stents are implanted into the blood vessel, mechanical properties must 
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match the application and maintain sufficiently strong until the surrounding tissue has been healed. 
It is noted that with the degradation of the polymers, there will be a corresponding change in the 
mechanical properties of stents, depending on the polymer and manufacturing process of the stents 
[22]. In addition, there should be nontoxic responses in the body when biodegradable stents, once 
implanted, are undergoing change through metabolism. Their by-products of biodegradation can 
be either into the metabolic cycle of the body or extruded outside the body. Finally, the polymers 
are able to transfer and release drugs into the blood vessel. The polymers for use in biomedical 
engineering, as reported in the literature, include poly (L-lactide) (PLLA), polyglycolic acid (PGA), 
poly(D-lactide) (PDLA), Polylactic acid (PLA) and poly (caprolactone) (PCL). Table 1 lists these 
biodegradable polymers and their properties important in the present research.  
Table 1 Biodegradable polymers used for stents 
Polymers 
Melting 
Point ((°C) 
Modulus 
(Gpa) 
Degradation 
time 
(Months) 
Biocompatibility 
Apply 
before 
 
References 
PLLA 173-178 2.7 ＞24 Good Stent [20, 21] 
PGA 225-178 7.0 6-12 
Mild 
inflammatory 
 [20] 
PDLA Amorphous 1.9 12-16  Coating [20] 
PLA 180-220 3.2 6-12 
No severe   
inflammatory 
Coating [22] 
PCL 59-64 0.4 ＞24 good 
Stent and 
Coating 
[20,23] 
 
PLA has been clinically used as a biomaterial for scaffold fabricated in tissue engineering, 
but difficulties in substituting the mechanical properties of metallic stents and destructive 
inflammatory reactions during polymers erosion leading to in-stent restenosis [24]. By comparison, 
an advantage of PLLA over other biomaterials is that it possesses high strength in mechanical 
property listed in table 1. However, PLLA degrades at a low rate due to being more hydrophobic 
than other biomaterials. It has been presented that high molecular weight PLLA can be absorbed 
totally in between 2 and 5 years in vivo [25]. Unlike PLLA absorbed slowly, PGA can be absorbed 
within approximately 6-12 months post-implantation because of greater hydrolytic susceptibility 
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[26]. A drawback of PGA stents is a lack of pliability. The Kyoto University reported that he PGA 
coil stent exhibited thrombus deposition in canine implant studies [27]. PDLA and PLA, similar 
with PLLA, have less strength than PGA. 
PCL has an extremely high elongation with low tensile strength, and extensive research 
focuses on developing various micro-and nano-sized drug-delivery vehicles based on PCL, which 
is promising to hold and release drugs. PCL is a hydrophobic, semi-crystalline polymer [28]; it is 
potential shape memory polymer with the ability to return from a deformed state to their original 
shape by temperature change. Shape memory materials are introduced for cardiovascular stents 
based on their self-expansion ability. Ajili et al. [29] have recommended a polyurethane/PCL blend 
material for shape memory stents. Polyurethane compound builded on poly (ɛ-caprolactone) diol 
was melt mixed with PCL in four different ratios (20, 30, 40 and 50 wt. %) and their shape memory 
behaviors were studied. The shape memory effects with recovery temperatures of around the 
melting temperature of PCL appears in all blends but Polyurethane/PCL (80/20). This study also 
evaluated the biocompatibility of Polyurethane/PCL (70/30) blend with human bone marrow 
mesenchymal stem cells. The results presented that the blend is good for cell adhesion and 
proliferation, which showed good biocompatibility and recommended that this blend might be a 
material for stent implant in the future. Based on good biocompatibility and moderate mechanical 
property, PCL has been chosen for the material of biodegradable stents in this project. 
 
2.3 Stents Structures 
Stent structure plays a pivotal role in the functionality of a vascular stent. Several criteria 
should be considered when designing structure of stents. First, stents need appropriate mechanical 
properties, such as the sufficient circumferential and radial stiffness to withstand the inward radial 
loading imposed on it by the surrounding vessel, while the device must simultaneously exhibit 
sufficient flexibility of its major axis to enable location within the curved geometry of the 
recipient's vessel. Second, the stent surface coverage should also be minimized to lower the risks 
of thrombosis and neointimal hyperplasia [30]. Typically, stent structures can be divided into two 
types; one is the coil design and the other is the zigzag design.  
2.3.1 Coil structure of biodegradable stents  
The coil biodegradable stents are usually constructed of polymer fibers and spring-like 
support structure in figure 1 (a), which is relatively easy to fabricate with wrapping polymer fibers 
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or dispensing systems. The coil stent is the most flexible and conformable, which is the key 
determinants of stent fracture, and it appears that the more flexible and conformable the stent, the 
less prone it is to fracture. However, mechanical properties of the coil biodegradable stents are 
weak, especially radial stiffness. In contrast to the metal wire, a polymer fiber coil stent cannot 
keep its original shape well with lower mechanical strength [31]. One of coil stents in figure 1(b) 
is that coils are encased in an envelope allowing the stent to be wound tightly [31]. The envelope 
includes an extension for each coil of the wire, which extension overlaps the neighboring coil when 
the stent is tightly wound and undeployed; additionally, it extends between the coil and its neighbor 
when the stent is deployed and unwound [31].  
(a)                          (b) 
Figure 1 Coil stents 
         
 
2.3.2 Zigzag pattern of biodegradable stents 
Zigzag patterns for biodegradable stents are widely used. A zigzag in Figure 2 is a pattern 
made up of small corners at variable angles, with a symmetric structure at the peak or valley point. 
The length of the line connecting peak and valley can be different in order to form a special zigzag 
pattern [32].  
 
Figure 2 Zigzag pattern 
Since a coil stent is made by simply bending a wire having flexibility, the coil stent is 
expanded not only easily, but also shrunk easily. Namely, the coil stent does not have enough 
support capability for maintaining the expanded situation in order to hold the body lumen open. 
On the other hand, a zigzag type stent has enough support capability to retain its expanded situation 
 9 
 
for holding the body lumen open. However, since the zigzag stent is not flexible in the axial 
direction, it is hard to deliver the zigzag stent and to locate the stent in the desirable site [33]. In 
the zigzag pattern stent, struts attached in zigzag shape are joined in the circumferential direction 
to form a tubular shape stent. Hence, when the stent is expanded, the struts in the zigzag shape 
expand in the circumferential direction (Figure 3 [33]).  
 
Figure 3 Zigzag stents 
2.4 Biodegradable stent products 
2.4.1 Igaki-Tamai Stent 
The first bioabsorbable stent implanted in humans was the Igaki-Tamai stent (Figure 4), 
which is formed of high molecular weight (321kDa) biodegradable polymer PLLA [34]. It has a 
zig-zag helical coils with 0.17mm strut thickness and takes more than three years for complete 
degradation in the human body. The stent expands by itself with an adequate temperature, and it 
is without a drug coating.  In the study [35], 25 stents were implanted in 19 lesions in 15 patients, 
and no stent thrombosis and no major cardiac event occurred within 30 days. The study suggests 
that the Igaki-Tamai stents are feasible, safe, and effective in humans. Long-term investigations 
with more patients will be required to validate the long-term efficacy of Igaki-Tamai stents.  
 
Figure 4 Igaki-tamai stent 
 
2.4.2 Absorb Bioresorbable Vascular Scaffold 
The Absorb Bioresorbable Vascular Scaffold (BVS) (Abbott, Santa Clara, CA) is the most 
advanced bioresorbable vascular scaffold. BVS is a small mesh tube, made from poly (L-lactide) 
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(PLLA), and coating with poly (D, L-lactide) (PDLLA) which can help release drugs. The scaffold 
can be expanded by a balloon and has two platinum radio-opaque markers [36]. 
The first –in- man trial indicated that the feasibility of the BVS. At 1 year, there were no late stent 
thromboses. Within 2 years’ clinical observation， vasomotion restored and the scaffold was safe 
without stent thrombosis or cardiac death [37]. Based on ABSORB trails, Abbott made some 
change to the Absorb BVS concentrated on improving the duration of vessel support without 
modifying other key design parameters. The product in multiple sizes, including 2.5mm, 3.0mm, 
and 3.5mm diameters and 12, 18, and 28mm lengths, is available now(Figure 5) [38].  
 
 
Figure 5 Absorb Bioresorbable Vascular Scaffold 
2.4.3 REVA Stent 
The first-generation REVA stent (REVA Medical, San Diego, California, United States) is 
made of a tyrosine-derived poly carbonate without drug- eluting and has a unique side-lock 
structure with a 0.2mm strut thickness to allow for safe expansion and provides excellent radial 
stiffness to withstand the redial force (Figure 6). Nevertheless, the results showed that there was a 
high restenosis rate secondary to focal mechanical failures in the human trial [39]. A redesign, the 
ReZolve 2 Scaffold, was reformed and is undergoing initial testing.  It utilizes an improved 
tyrosine polycarbonate polymer that provides a 30% increase in radial stiffness [40]. 
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Figure 6 ReZolve Sirolimus-Eluting Bioresorbable Coronary Scaffold with slide and lock mechanism 
 
2.5 Methods for Fabricating Biodegradable Stents 
Commonly, there are two types of fabrication methods for stents fabrication. Top-down 
fabrication approaches, such as laser machining, molding, and electroforming, are subtractive 
processes starting from bulk materials, while bottom-up fabrication strategies, such as solvent 
casting and 3dimensional (3D) printing, are additive processes [41]. Applications of both methods 
to the stent fabrication are briefly reviewed in the following.  
Laser machining commonly used stent fabrication process is basically a two-step process, 
i.e., a polymer tube created and then cut by laser to form stents. Compared to other cutting methods, 
laser processing produces very smooth edges that substantially reduce the need for finishing the 
process. The benefit of which is the ability to make intricate design cuts with extreme precision 
and accuracy. However, this two-step process is time-consuming and not efficient in using 
biodegradable polymers.  Laser machining has been used to produce polymeric stents, such as 
REVA stents, however, alterations may be made when concerning thermal and chemical polymer 
properties.  
Injection and compression molding processes are particularly appropriate for polymeric 
materials due to their thermoplastic behavior with recent efforts directed at optimizing micro-and 
nano-molding processes [41-44]. Injection and compression molding (ICM) combines the 
techniques of both injection molding and compression molding. In the injection and compression 
molding process, heat and pressure are exerted on the molding cavity, causing it to solidify into 
the mold shape [45]. ICM not only keeps the advantages of conventional injection molding but 
also increases the reproduction of micro-surface feature and reduces flow distance/wall thickness 
ratio.  However, it is not easy for the user to implement ICM process, as the melt penetrating to 
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the parting line can be caused by late compression while incomplete filling may be caused by early 
compression.    
Fused deposition molding (FDM) consists of repeated deposition of thin layers of polymer 
and assembling the layers into 3D microstructures [46]. Moreover, melt spinning can be used to 
form bioabsorbable polymer fibers in the range of 150 µm to 200 µm that can then be woven or 
knitted into stent-like structures [47, 48]. These two fabrication techniques are still in their early 
stages, and further study is needed. Also, the available materials for FDM are restricted due to the 
melting points.   
3D-Bioplotter has been widely utilized in tissue engineering to fabricate tissue scaffolds 
by taking advantage of dispensing based rapid prototyping techniques. The benefits include precise 
control over microstructure, good repeatability, capacity for adapting to different materials states, 
from liquid to a thick paste, and relatively mild fabrication condition such as low operating 
temperature, no toxic solvent needed, and fast and efficient material processing [14]. 3D-Bioplotter 
has evolved into an innovative rapid stent fabrication technology for fabricating biodegradable 
stents. Through this novel biodegradable stent fabrication system, polymer stents with various 
patterns can be directly made from polymer powders, such as PCL, PLA, and PLLA.  Therefore, 
this technology has shown sound promising to be able to accelerate the stent product development 
process. 
Based on the discussion above, the advantages and disadvantages of fabrication methods 
for biodegradable stents are summarized below (Table 2). 
Table 2 The advantages and disadvantages of fabrication methods for biodegradable stents 
Fabrication Advantages Disadvantages 
Laser cutting 
produce small diameter tube 
high precision  
low cost 
Heat effects 
Deposition of the removed 
material 
Injection and compression 
molding 
Fast production 
Low cost 
Second operation  
Design restrictions 
Fused deposition molding  
Fast fabrication 
High precision 
Heat effects 
Noddle diameter limitation 
3D-Bioplotter 
Precise control 
Low cost 
High efficiency 
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2.6 Radial stiffness test of stents 
Stents with high radial stiffness can help to resist early recoil caused by the artery pressure. 
The radial stiffness of stents was investigated in [49], aiming to simulate and evaluate the 
deformation of the stents caused by the artery pressure. The test platform included a Plexiglas 
cylindrical chamber that can be filled with water for pressure control. Additionally, a transparent 
polyurethane tube filled with water was used as an interface casing for ensuring uniform pressure 
applied on the stents, and the inner pressure was remained at the average pressure in the artery 
(100mmHg). The pressure inside the chamber was controlled by a pressure reducing device and 
measured, and then the diameter of the stents was measured by graduated ruler. From the measured 
stent diameters under different pressures, the stent deformation behavior can be characterized. 
 
Figure 7 Radial stiffness test platform 
2.7 Conclusions 
Based on the concept that biomaterials can be degraded, biodegradable stent-assisted 
coiling is expected to be the ideal treatment of wide-neck complex aneurysms.  Currently, there 
are some products approved for clinical use. Although the short-term results are charming, there 
are still some concerns such as the weaker mechanical properties of structure and the time-
consuming and low-level repeatable fabrication techniques. Therefore, the further studies of 
structure design and fabrication method are needed. Stent design develops in a manner adopting 
novel strategies driven by the improvement of material science, microfabrication, and 
nanotechnology. 
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CHAPTER 3 Fabrication of Biodegradable Stents 
 
3.1 Fabrication of Stents Based on Rapid Prototyping Dispensing Method                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
Various rapid prototyping systems have been developed to fabricate scaffolds for tissue 
engineering, including the biodegradable stents, because rapid prototyping technology not only 
allows more choice of biomaterials but provides more precise control in the whole fabrication 
process. Typically, the rapid prototyping system is a computer-controlled three-axis machine with 
a dispenser head, where the biomaterial in a form of fluid or solution stored a syringe is dispensed 
out by using air pressure, forming the biodegradable stents while the head is brought to move along 
three axises. 
 In the present study, a fluid dispensing equipment (Figure 7) supplied by Nordson 
Asymtek is used in fabricating biodegradable stents. Through this fluid dispensing equipment, the 
biodegradable stents can be manufactured with a minimum strand diameter of 0.1 mm. The main 
parts of the equipment includes a dispensing head, a high-resolution camera, a z-height sensor and 
a syringe. Specifically, the dispensing head is controlled by high precision motors with a 
movement resolution of 0.001 mm, and the speed is controlled from 0.1 mm/s to 150 mm/s. 
Additionally, a high-resolution camera is used for needle tip positioning and strand dimension 
control. For automatically controlling the height of the head, a z-height sensor is built in. 
Furthermore, there is a fluid pressure gauge indicating the air pressure supplied to the syringe. The 
fluid pump dispenses the liquid and is mounted on the dispensing head, and holds the syringe of 
dispensing fluid.  
 To fabricate biodegradable stents, a motorized cylindrical substrate (Figure 8) will be used. 
On the substrate, a replaceable mandrel is connected to the shaft of an electric motor via a spindle; 
as such the mandrel can be rotated by the electric motor in a controlled manner. Then, the 
biomaterials can be dispensed onto the surface of the mandrel via the dispensing machine. The 
fluid dispensing mechanism (Figure 9) is so configured that its dispensing head can move along 
the mandrel in a controlled manner while distributing the biomaterials onto the top surface of the 
mandrel at a controllable flow rate. During the fabrication process, the rotational motion of the 
mandrel and the translational motion of the fluid dispensing head are coordinated such that the 
fluid dispensing head traces and dispenses biomaterials to the designed location of the strands of 
the stent being built, thus forming the stent on the surface of the mandrel. 
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Figure 8 Nordson Asymtek dispensing machine 
 
   
Figure 9  Motorized cylindrical substrate 
 
Figure 10 Dispensing mechanism for fabrication biodegradable stents 
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3.2 Material Preparation and Stent Fabrication  
3.2.1 Material Preparation 
Polycaprolactone (PCL) powder (MW 50,000) was obtained from Polysciences, Inc. A 
solvent of chloroform was used, and the concentration of polymer used varied from 50%PCL to 
70%PCL. Due to the toxic solvents and the requirement for careful handling, all solutions were 
prepared under a chemical hood. First the polymer was weighted, 5g, 6g and 7g, for 50%, 60% 
and 70% concentration solutions respectively, and then put into a glass jar for each one. 
Subsequently, the chloroform was made in 10ml quantities for each glass jar and added into the 
glass jar with a stirring rod to obtain a homogeneous solution. The glass jar was then sealed and 
ready for pouring into a syringe, which was used for dispensing. All solutions were prepared at 
room temperature.  
3.2.2 Stent Fabrication Process 
The coil stents and zigzag stents mentioned in chapter 2 will be fabricated in this section, 
and the fabrication parameters including fluid pressure, dispensing head moving speed, needle size 
of the dispensing head, mandrel rotating speed and dispensing head height will be investigated.                                
For achieving the desired accuracy, parameters should be adjusted and matched well. The 
PCL solution will be dispensed and solidified onto a mandrel, which rotates in a controlled manner, 
thus forming the structure as shown in a schematic (Figure 10). To accurately deposit the 
designated material distribution, the flow rate of material and moving speed of the dispensing head 
will be carefully determined. The flow rate is affected by the concentration of fluids, the needle 
size of the dispensing head and the air pressure in the syringe. Also, the angular velocity of the 
mandrel and the moving speed of the dispensing head will be coordinated and programmed to 
fabricate the coil and zigzag biodegradable stents (Figure 11). 
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Figure 11 Schematic of fabrication process of biodegradable stents 
 
 
Figure 12 Fabrication process of biodegradable stents 
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3.3 Characterization of Stents Fabricated 
3.3.1 Parameters for Coil Structure with Different Concentration of PCL solution 
Working parameters are essential for stents fabrication. Those parameters can be broadly 
divided into six parts such as the concentration of PCL solution, air pressure, dispensing height, 
dispensing speed, mandrel rotating speed and diameter of the needle of dispensing head (Table 3).  
 
Table 3 Fabrication parameters for coil structure of biodegradable stents 
Coil Structure 
Label 
Concentration 
of PCL 
solution 
Air 
pressure 
(psi) 
Dispensing 
height 
(inch) 
Dispensing 
Speed 
(Inch/sec) 
Mandrel 
rotating 
speed 
(rpm) 
Diameter 
of needle  
Dispensing 
head (mm) 
Samples 
Coil 50 50%PCL 30 1.74 0.7 402 0.25 
 
Coil 60 60%PCL 30 1.74 0.7 402 0.41 
 
Coil 70 70%PCL 30 1.74 0.7 402 0.41 
 
 
The concentration of PCL solution plays a pivotal role in the coil formation during the 
fabrication process. Three levels from low to high are utilized in this experiment. As the low 
concentration leads to the low viscosity, the smaller diameter of the needle for the dispensing head 
has to be used so that the struts can solidify on the mandrel and not to flow out of the mandrel. 
70% PCL solution matches well with the 0.41 mm diameter of the needle for the dispensing head 
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while the 60% PCL solution cannot form a round strut through 0.41 mm diameter of the needle for 
the dispensing head because of its low viscosity. Air pressure and dispensing height also have a 
significant effect on the flow rate of the PCL solution within the syringe. If the flow rate is 
relatively high or low, the bead strut from the syringe will come out rather than a smooth one. So, 
the air pressure and dispensing height are adjusted at 30 psi and 1.74 inches respectively for a 
stable strut. For the coil structure, the mandrel rotating speed has to be relatively high (402 rpm) 
and the speed of dispensing head is moderate (0.7 inches/sec) to keep an average pitch of the coil 
structure stents. 
 
3.3.2 Parameters for Zigzag Structure with Different Concentration of PCL solution 
There is also three concentration of PCL solutions for fabricating zigzag stents (Table 4). 
Table 4  Fabrication parameters for zigzag biodegradable stents 
Zigzag Structure 
Label 
Concentration 
of PCL 
solution 
Air 
pressure 
(psi) 
Dispensing 
Height 
(inch) 
Dispensing 
Speed 
(Inch/sec) 
Mandrel 
rotating 
speed 
(rpm) 
Diameter 
of 
Dispensing 
head (mm) 
Samples 
Zigzag50 50%PCL 30 1.74 0.7 232 0.25 
 
Zigzag60 60%PCL 30 1.74 0.7 232 0.41 
 
Zigzag70 70%PCL 30 1.74 0.7 232 0.41 
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As the same with coil structure, 70% of PCL solution matches the 0.41 mm diameter of the 
needle for the dispensing head very well, while the 50% PCL solution is suitable for 0.25 mm 
diameter of the needle for the dispensing head. The air pressure and dispensing height are the same 
with the values for fabricating the coil structure, as the flow rate is proper for forming the smooth 
struts. The mandrel rotating speed (232 rpm) in fabricating zigzag structure is much slower than 
making coil structure because it costs more time for the dispensing head to move forward and back 
to form a zigzag pattern. The numbers of the zigzag in one row determine the mandrel rotating 
speed and the speed of dispensing head, which means that the low mandrel rotating speed allows 
more forward and back movements.  
 
3.3.3 Parameters for Zigzag Structure Made of 70% PCL solution 
In order to obtain a zigzag structure with better mechanical property stents, another 
experiment was carried out to investigate the parameters of fabricating the 70% PCL solution. The 
speed of dispensing head is the importance of forming a zigzag structure of biodegradable stents, 
which will be changed from 0.7 to 1.3 inch/sec in this experiment while other parameters keep the 
same value (Table 5). Through comparison, when the speed of dispensing head is at 0.85 
inches/sec, the zigzag structure of biodegradable stent fabricated looks better than others. The 
property of radial deformation of all of the biodegradable stents was examined by a compression 
test, as presented in the next chapter. 
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Table 5 Fabrication parameters for 70% PCL of zigzag biodegradable stents 
Zigzag Structure 
Label 
Concentration 
of PCL 
solution 
Air 
pressure 
(psi) 
Dispensing 
Height 
(inch) 
Dispensing 
Speed 
(Inch/sec) 
Mandrel 
rotating 
speed 
(rpm) 
Diameter 
of 
Dispensing 
head (mm) 
Samples 
Zigzag70-
0.7 
70%PCL 30 1.74 0.7 232 0.41 
 
Zigzag70-
0.85 
70%PCL 30 1.74 0.85 232 0.41 
 
Zigzag70-
0.9 
70%PCL 30 1.74 0.9 232 0.41 
 
Zigzag70-
1.1 
70%PCL 30 1.74 1.1 232 0.41 
 
Zigzag70-
1.3 
70%PCL 30 1.74 1.3 232 0.41 
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3.4 Conclusions 
This chapter presents the process of fabricating biodegradable stents, and the results show 
that the dispensing-based rapid prototyping method is a promising technique for fabricating 
biodegradable stents. With the successful coil and zigzag structures, this method is controllable 
and able to fabricate more various structures of biodegradable stents. 
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CHAPTER 4 Compression Test of Biodegradable Stents 
 
4.1 Introduction to the Compression Test System 
The radial stiffness, a measurement of the radial rigidity of the biodegradable stents, is of 
importance for the reduction of target vessel restenosis, as the radial stiffness can present the extent 
to resist radial deformation of biodegradable stents in response to an applied force [49]. The 
compression test is an efficient examination method to investigate the radial stiffness of 
biodegradable stents, which can determine deformation behaviors of biodegradable stents under 
loads.  This chapter is intended to provide a compression comparison of radial deformation among 
biodegradable stents including coil and zigzag structure fabricated in Chapter 3. Specifically, the 
biodegradable stents will be compressed, and the displacement at various loads will be recorded.  
An advanced design of the Bose Dynamic testing platform to evaluate the deformation of 
biodegradable stents will be employed (Figure 12), which can provide an accurate characterization 
of biomaterials and biological samples within a sterile cell culture media environment. 
Specifically, Bose Dynamic test instruments are integrated systems that combine ElectroForce 
linear motors with environmental technologies and fully-automated computer control. Proprietary 
ElectroForce motors provide exceptional fidelity based on their simple and durable moving-
magnet design. The Bose Dynamic test instrument is controlled by a PC using Bose PCI digital 
controls and WinTest software while the WinTest software is an intuitive control system for 
performing complex test routines with minimal training. Additionally, measurement transducers 
are provided for each active control channel, including pressure sensors, axial load and 
displacement measurement.  
After loading the sample on the plates, parameters including displacement and compression 
rate are needed to set for the compression test (Figure 13). In this experiment, the desired 
displacement is specified manually with a value of -1.8 mm, and the compression rate is set at 
0.1mm/sec.  
For data acquisition, there are many ways to record data. It is recommended to use timed 
data from data acquisition tab in the window (Figure 14). The desired measuring time in Scan 
Time as seconds can be defined. The Scan Points representing the number of data will be acquired 
in the specified Scan Time. In this experiment, the measured time is 100 s for each stent, and 1000 
 24 
 
points are being scanned within 100 s. Then the location and name for the data file can be chosen 
for saving. 
 
 
Figure 13 Bose ElectroForce Biodynamic testing system 
 
Figure 14 Displacement and compression rate setting 
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Figure 15 Data acquisition setting 
 
4.2 Experiments Design and Procedure 
This experiment aims to determine the deformation of coil and zigzag structure of 
biodegradable stents under a compressive load through Bose ElectroForce BioDynamic test 
instrument. During the experiment, loads and displacements are intermittently measured and 
recorded.  
Compression tests are conducted by loading specimen between two plates (Figure 15), and 
then applying a force to the sample by moving the crossheads underneath. During the test, the 
biodegradable stents are compressed, and displacements versus the applied loads are recorded. 
 
Figure 16 Loading plates for specimen 
  
The diameter of coil and zigzag structure of biodegradable stents is the same (3.4 mm). 
The forces required to compress the stents radially by 10% (0.34 mm), 20% (0.68 mm), 30% (1.02 
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mm) and 40% (1.36 mm) will be measured. Nine groups of biodegradable stents need to be tested, 
and there are four stents in each group. The letters from A to G are used to represent each group 
of zigzag biodegradable stents for distinguishing different fabrication parameters and different 
concentration solution.  The concentration of solution of biomaterials is the same (70%) from A 
to E, while the fabrication parameter (the speed of dispensing head) is different (0.85 inch/sec, 0.7 
inch/sec, 0.9 inch/sec, 1.1 inch/sec and 1.3 inch/sec, respectively).  F and G represent the 60% and 
50% zigzag biodegradable stents when the speed of dispensing head is at 0.7 inch/sec. Coil A and 
coil B stand for coil structure of biodegradable stents at the concentration of 50% and 70% 
respectively.   
4.3 Testing Results and Discussion 
This test examines the following characteristics: radial deformation of biodegradable stents 
with the compressive force.  All the biodegradable stents are compressed in a similar elliptical 
shape configuration. Comparing with the forces required to compress the biodegradable stents 
radially by 10%, the largest force is 0.214 N for Group A, and the second one is 0.179 N for Group 
F. The result means that the zigzag structure in group A can bear more compression forces than 
other groups and indicates that the zigzag structure in Group A can potentially support the blood 
vessel in order to make the blood flow fluently (Figure 16).   
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Figure 17 10% radial compression of biodegradable stents 
 
 
There is no significant difference between the largest force and the second one when 
compressing the biodegradable stents radially 20%, which are 0.445 N in group A and 0.438 N in 
Group F respectively (Figure 17).  
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Figure 18 20% radial compression of biodegradable stents 
 
The largest force can compress biodegradable stents radially 30% is 0.813 N in Group A 
while the second one is 0.713N in Group F (Figure 18). 
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Figure 19 30% radial compression of biodegradable stents 
 
To compress biodegradable stents radially 40%, the force in Group A is 1.342N, with a 
27% larger than the second one (Figure 19). 
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Figure 20 40% radial compression of biodegradable stents 
 
4.4 Conclusions 
The compression test results indicate that the radial stiffness of zigzag biodegradable stents 
is better than the coil stents, and shows the zigzag biodegradable stents in Group A have the highest 
radial stiffness for bearing compressive forces. The compression test will be modeled and 
simulated in the next chapter. 
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CHAPTER 5 Modeling of Biodegradable Stents and Simulation of Compression Test with 
the Finite Element Analysis Method 
 
5.1 Introduction to Modeling of Biodegradable Stents and Simulation Method with Finite 
Element Analysis 
This chapter presents a parametric design approach to model zigzag structures of 
biodegradable stents and a finite element analysis method to simulate real compression test of the 
biodegradable stents performed in Chapter 4. 
Solid modeling is a geometrical representation of a real object without losing information 
which the real object would have. Thus, if the density of the material is given, the mass and inertia 
of the solid modeling can be calculated with its volume [51]. The solid modeling of biodegradable 
stents will be built with Pro/Engineer software, which is a feature-based solid modeling tool. 
Conveniently, each feature can be edited individually and can be changed in the solid modeling. 
Pro/Engineering is parametric in nature, which means that the characteristics of the part are 
correlative by taking the reference of each other. It is easy to redefine the dimensions or the 
attributes of a feature with Pro/Engineer based on the users’ requirements, and the changes will be 
executed automatically throughout modifying the parameters of modeling. The zigzag structure of 
biodegradable stents is represented by several parameters, and thus, the parametric modeling 
allows any of the characteristic parameters of the zigzag structure to drive the modification in order 
to build different models.  
The finite element analysis [52] is a numerical method to be applied in structural analysis, 
solid mechanics and dynamics etc. ANSYS Workbench, a professional tool for the finite element 
simulation, is the framework combining an industry-leading suite of advanced engineering 
simulation technology. In the ANSYS Workbench [53], the complex Multiphysics analyzes can 
be carried out with a simple drag-and-drop through an innovative project schematic. For simulating 
a compression test, the parametric modeling of biodegradable stents built by Pro/Engineer will be 
linked into ANSYS Workbench, and a static structural analysis system in ANSYS Workbench will 
be used to determine the deformation of biodegradable stents under different compression forces.  
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5.2 Parametric Modeling of Zigzag Structure of Biodegradable Stents  
5.2.1 Parameters of biodegradable stents 
Based on the biodegradable stents fabricated by the dispensing-based rapid prototyping 
machine in Chapter 3, the thickness of the strut is 0.41 mm, and the diameter of the stent is 3.4 
mm. The model can be built on a flat surface first, and then bended into a tube shape in the 
Pro/Engineer software. The flat surface of zigzag biodegradable stents can be divided into small 
cells. There are five zigzag cells in each row along the circumferential direction, and six rows in 
the axial direction (Figure 20). 
 
Figure 21 Zigzag pattern of biodegradable stents 
There are three parameters to represent a zigzag cell in the axial direction (Figure 21). The 
one denoted by A in Figure 21 is the diameter of curvature at the apex that is tangential to the line 
on each side in the circumferential direction. As the diameter of curvature changes, the angle 
between two lines will be altered. The one denoted by B is the vertical length of the line tangential 
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with the semi-circle. The one denoted by C is the distance between two apexes of the semi-circles. 
A new structure can be obtained by changing the size of the parameters. Initially, A is 0.25 mm; 
B is 2.8 mm and C is 0.8 mm.  
 
 
Figure 22 Parameters for each cell of zigzag biodegradable stents 
A 
 
B 
 
C 
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5.2.2 Process of parametric modeling of zigzag biodegradable stents 
The process of creating the parametric model of zigzag biodegradable stents with 
Pro/Engineer software will be introduced in the following.  
First, a 2D zigzag structure (Figure 22) can be drawn in the Sketch. The Sketcher toolbar 
appears to the right of the graphics window. It is convenient to use these Sketcher tools to sketch 
the curve and a tangential line to form a 2D zigzag structure in the Figure 20. 
      
Figure 23 Sketch and tool bar in the Pro/Engineer 
  
Then, a 3D zigzag structure (Figure 23) can be created by a Sweep feature through taking 
a sketched profile and sweeping it along a selected or sketched trajectory.  The cross-section of 
the feature along the entire length of the trajectory is constant. The cross-section is a circle with 
0.41 mm in diameter, which is based on the needle size of  the dispensing head used in fabricating 
the biodegradable stents.   
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Figure 24 3D flat surface of biodegradable stents by sweep feature 
 
Finally, the function of Toroidal Bend (Figure 24) is used to shape the flat surface into the 
tube. The Toroidal Bend command can bend solids, surfaces or datum curves into shapes. This 
command gets accustomed to creating tire-like structures, where the customers need to create 
operations on a flat surface and then bend it. 
 
Figure 25 Toroidal Bend feature in Pro/Engineer  
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Figure 26 Model of biodegradable stents built in Pro/Engineer 
Through the main three features, a 3D parametric model of the zigzag stent has been created 
(Figure 25). In the next section, the 3D parametric model will be used to simulate the compression 
test, which has been carried out in chapter 4.  
5.3 Simulation of Compression Test with the Finite Element Analysis Method 
The simulation of compression test of biodegradable stents will be performed by a static 
structural analysis that can determine the displacements, stresses, strains, and forces in structures 
or components caused by loads that do not induce significant inertia and damping effects [54]. 
Steady loading and response conditions are assumed; that is, the loads and the structure’s response 
are assumed to vary slowly with respect to time. The results of the simulation will show the load-
displacement curve for the biodegradable stents. 
For a linear static structural analysis, the displacements {x} are solved in the matrix 
equation below [55]: 
                                                       [K]{x} = {F}                                                                   (5.1)        
This results in certain assumptions related to the analysis: 
- [K] is essentially constant. The linear elastic material behavior is assumed, and small deflection 
theory is used. 
- {F} is statically applied. No time-varying forces are considered, and no inertial effects (mass, 
damping) are included. 
 37 
 
5.3.1 Procedure of Finite element simulation 
1. Project Schematic  
The innovative project schematic view can transform the way engineers work with the 
simulation. Projects are represented graphically as connected systems in a flowchart-like diagram.  
There are many systems for specific analysis in Toolbox, and each system in the Toolbox can be 
dropped into the Project Schematic window as shown in Figure 26. The system of Static Structural 
analysis is selected and dropped; then, the Geometry can be linked and shared. 
 
Figure 27 Project schematic view  
 
2.  Geometry Import 
It is more efficient to import the CAD model into ANSYS than to re-create it if the 
geometry of the part has been created. There are various import options available in ANSYS, such 
as IGES Imports and Connection Products. IGES importing works quite easily, but because of the 
dual translation process- CAD – IGES- ANSYS, in many cases where it does not function well. 
While ANSYS Connection products overcome this problem by directly reading the “native” part 
files produced by the CAD package like connection for Pro/Engineer (Figure 27). The geometry 
of biodegradable stents is imported directly from Pro/Engineer to ANSYS in this simulation 
process (Figure 28).   
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Figure 28 Geometry import process 
 
Figure 29 Geometry of model 
3.  Material properties 
The Engineering Data Manager in ANSYS Workbench provides a powerful tool for 
defining, organizing, and storing material properties. A great variety of material models are 
available in the Toolbox menu, and material data can be stored in libraries that can be accessed in 
any project. The biodegradable stent is made of PCL while the compression plates are made of 
structural steel. The material properties [56] defined are density, Young’s Modulus and Poisson’s 
Ratio (Fig. 29-31).  
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Figure 30 Engineering data manager 
 
Figure 31 Properties of PCL (material of biodegradable stent) 
 
Figure 32 Properties of Structural Steel (material of compression plates) 
4.  Meshing  
Meshing is an essential part of the computer-aided engineering simulation process. The 
mesh influences the accuracy, convergence and the speed of the solution. Furthermore, the time 
that it takes to create and mesh a model plays a significant role in the time it takes to get results 
from a CAE solution. Therefore, the better and more automated the meshing tools, the better the 
solution. The Mesh Tool in ANSYS Workbench provides an accessible path to many of the most 
common mesh controls. The Tetrahedral meshing method is used for meshing biodegradable 
stents. This method uses a bottom-up approach (creates a surface mesh then volume mesh), and 
multiple triangular surface meshing algorithms are applied to ensure a high quality (Figure 32) 
[57]. The surface mesh is generated first, and then from the surface mesh, inflation layers can be 
grown. There are 99249 nodes and 43712 elements totally in Figure 33. 
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Figure 33 Meshed biodegradable stents with plates 
 
Figure 34 Numbers of nodes and elements 
 
5. Boundary Conditions 
Based on the equipment in the real compression test, the upper plate is fixed, and the plate 
below can be moved with the force applied. Therefore, the fixed support is used on the top plate 
(Figure 34), and the displacement of X and Y direction on the lower plate is zero while the 
displacement of z-direction is free. Additionally (Figure 35), the initial force is - 0.2 N with the 
opposite Z direction (Figure 36).  
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Figure 35 Fixed support on the upper plate 
 
 
Figure 36 Displacement setting on the lower plate 
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Figure 37  Force applied on the lower plate 
5.3.2 Results 
The results present the total deformation of biodegradable stents. According to the real 
compression test, the forces required to compress biodegradable stents radially 10% (0.342mm) is 
0.199 N. When the force is 0.199 N applied in the simulation, the total deformation of the 
biodegradable stent is 0.304 mm (Figure 37), the error is 11.11%. Then the force compressing 
biodegradable stents radially 20% is applied on the biodegradable stent in the simulation, and the 
total deformation of the biodegradable stent are 0.681 mm, and the error is 0.29% compared with 
the real compression test (0.679 mm in Figure 38).  
The deformation comparison of biodegradable stents between simulation and actual 
compression test shows in Table 6 and the curve comparison is presented in Figure 39. The 
relationship between force and deformation is linear in the simulation of ANSYS Workbench 
while in the actual compression test the relationship between force and deformation is non-linear. 
The error based on the comparison results (the maximum error 13.14%) is insignificant, indicating 
that the finite element model is acceptable within the range of around 20% radial deformation.   
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Figure 38 Deformation of compressing biodegradable stents radially 10% 
 
Figure 39 Deformation of compressing biodegradable stents radially 20% 
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Table 6 Deformation comparison between simulation of biodegradable stents and real compression test  
Force  
(N) 
Maximum Total 
Deformation in 
Simulation (mm) 
Deformation in 
Compression Test (mm) 
Errors 
0.026 0.040 0.036 11.11% 
0.049 0.075 0.069 8.70% 
0.072 0.110 0.101 8.91% 
0.085 0.130 0.136 -4.41% 
0.107 0.163 0.174 -6.32% 
0.120 0.183 0.206 -11.17% 
0.139 0.212 0.238 -10.92% 
0.156 0.238 0.274 -13.14% 
0.176 0.269 0.306 -12.09% 
0.199 0.304 0.342 -11.11% 
0.222 0.339 0.376 -9.84% 
0.249 0.380 0.406 -6.40% 
0.271 0.414 0.444 -6.76% 
0.295 0.451 0.475 -5.05% 
0.332 0.507 0.513 -1.17% 
0.354 0.541 0.544 -0.55% 
0.375 0.573 0.576 -0.52% 
0.406 0.620 0.616 0.65% 
0.425 0.649 0.644 0.78% 
0.446 0.681 0.679 0.29% 
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Figure 40 Total deformation and force relationship comparison between FEA and real compression test 
 
5.4 Conclusions 
The deformation comparison of biodegradable stents between simulation and actual 
compression test shows that the finite element model for simulating the compression test can be 
accepted within the range of around 20% radial deformation. The simulation model of 
biodegradable stent is to be used for optimization of stents, as presented in the next chapter to 
improve the radial stiffness.    
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CHAPTER 6 Optimal-Design of Biodegradable Stents and Simulation of Biodegradable 
Stents in the Blood Vessel 
 
6.1 Introduction to Optimization Methods in ANSYS Workbench 
A brief introduction to parametric optimization based on Static Structure simulations is 
presented. ANSYS DesignXplorer is a design optimization application that works under the 
ANSYS Workbench environment [60]. ANSYS DesignXplorer interacts with all ANSYS 
Workbench platform components and leads CAD packages directly such as Pro/ENGINEER so 
that design changes can be quickly made to the design database [60]. Therefore, the simulation 
model of biodegradable stents built in chapter 5 can be used for parametric optimization. The 
instantaneous feedback on design modifications provided by ANSYS DesignXplorer dramatically 
decreases the number of design iterations.  
The DesignXplorer’s systems (parameters correlation, direct optimization, response 
surface, and response surface optimization or Six Sigma analysis) to the Workbench schematic are 
with drag-and-drop simplicity (Figures 40 and 41). Response surface systems are equipped with a 
variety of design of experiment (DOE) algorithms to efficiently and scientifically sample the 
design space. The main idea of response surface methodology is to use a sequence of designed 
experiments to obtain an optimal response. The resulting approximation of the output parameter 
as a function of the input variables is called the response surface.  Single- and multi-objective 
optimization algorithms can use the multi-dimensional response surface to find the optimal design 
quickly. Advanced direct optimization is also useful, along with adaptive optimization algorithms 
that combine the best function of response-surface and direct optimization [61].  
 
Figure 41 DesignXplorer’s systems 
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Figure 42 Project Schematic of parametric optimization of biodegradable stents 
The goal here is to determine the parameters of the biodegradable stent that offer the 
minimum radial deformations under the given force. With the design of experiments, several 
combinations of the parameters are created as “design points”. By running the analysis for each 
design point and recording the output, a mathematical formula was fitted to the data, which is 
called a “response surface.” The parameters are determined from this formula with a significant 
effect on the outputs. 
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6.2 Optimization of the Biodegradable stents with DesignXplorer  
6.2.1 Design of Experiment 
In the project setup, design optimization requires identification of input and output 
parameters. The input parameters are geometric parameters （A, B and C）defined in Chapter 5 
(Figures 42 and 43). The output parameter is the deformation of the biodegradable stent. Each 
combination of input parameters used is called a design point. The design of experiments specifies 
changes in input parameters to observe the corresponding output response (Figure 44).  
 
Figure 43 Input and output parameters in design of experiments 
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Figure 44 Values setting for input parameters 
 
 
Figure 45 Design of experiments type 
 
6.2.2 Response Surface and sensitivity 
In statistics, response surface methodology explores the relationships between several 
explanatory variables and one or more response variables. The major idea of response surface 
(a) Parameter A (b) Parameter B 
(c) Parameter C 
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method is to use a sequence of designed experiments to obtain an optimal response (Figure 45). A 
second-degree polynomial model is suggested for use because such a model is easy to establish 
and apply (Figure 46). Once the relationship is determined, the resulting approximation of the 
output parameter as a function of the input variables is called the response surface. 
 
Figure 46 Input and output parameters in response surface 
 
Figure 47 Response surface type 
The response surface charts show the relationship between parameters (A, B, and C) and 
total deformation in Figures 47- 49.  As defined in Chapter 5, A is the diameter of curvature at the 
apex. As the diameter of curvature changes, the angle between two lines will be altered. B is the 
vertical length of the line tangential with the semi-circle. C is the distance between two apexes of 
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the semi-circles. In Figure 47, the total deformation has little changed with the parameter A at 
range from 0.21 mm to 0.3 mm. The line in Figure 48 grows quickly, which means that parameter 
B plays a significant role in total deformation of biodegradable stents. When parameter B is 2.4 
mm, the total deformation is approximately 0.38mm. While the total deformation is about 0.78 
mm when parameter B is 3.2 mm. The result shows that the better total deformation can be 
obtained by reducing the length of the line tangential with the semi-circle.  Figure 49 shows that 
the minimum total deformation can be obtained when parameter C is around 0.8 mm. Apparently, 
the larger distance between two apexes of the semi-circles causes more deformation of the 
biodegradable stents.  
 
Figure 48 2D Response chart for total deformation and parameter A 
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Figure 49 2D Response chart for total deformation and parameter B 
 
Figure 50 2D Response chart for total deformation and parameter C 
 
The charts below are the 3D response charts for total deformation and parameters. Axes of 
X and Y represent the different parameters while Z-axis represents the total deformation of 
biodegradable stents. From Figure 50, it can be seen that the total deformation increases with the 
growth of parameter B, as parameter A has little effect on the total deformation. In Figure 51, the 
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trend of the total parameter is the same as the 2D response chart (Figure 49), as the parameter C 
plays greater role than parameter A. Figure 52 shows that the total deformation of biodegradable 
stents is influenced by both parameter B and C.  
 
Figure 51 3D Response chart for total deformation, parameter A and parameter B 
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Figure 52 3D Response chart for total deformation, parameter A and parameter C 
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Figure 53 3D Response chart for total deformation, parameter B, and parameter C 
 
 6.2.3 Sensitivity Analysis  
The sensitivity can be a powerful exploration tool to represent the impact of the input 
parameters on the output parameters.  The resulting chart provides the weight of the different inputs 
for the output. In the Fig. 53, it shows that Parameter B has a significant effect on the total 
deformation, while Parameter A has little influence on the total deformation. Parameter C displays 
the medium impact on the total deformation of biodegradable stents.  
 
 56 
 
 
Figure 54 Sensitivity Analysis 
6.2.4 Optimization process and results 
In the optimization properties, one or more objectives with or without constrains can be set 
(Figure 54). The direct optimization component in ANSYS Workbench offers several methods for 
single and multi-objective optimization such as Screening, Multi-objective generic algorithm and 
Nonlinear Programming by quadratic Lagrangian. In this project, the screening method is used, 
which is a simple approach based on sampling and sorting. A screening method is a direct method 
that creates a sample set of the design points and sorts them based on the objectives. It is a powerful 
way of obtaining the approximate vicinity of global minima and is proper for use in preliminary 
design [55]. There are 10000 samples to sort for the objective shown in Figure 55.  
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Figure 55 Outline of schematic for optimization 
 
Figure 56 Optimization method settings 
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Figure 57 Candidate designs 
The optimization results are now shown with ratings (the more stars, the better). Candidate 
point 1 is in this case the best choice, among the 10000 sampled points, and the total deformation 
of biodegradable stents will be 0.3783 mm (Figure 56). Compared with the initial total deformation 
(0.5887 mm) when applying the force (-0.4N) to compress the biodegradable stent, it decreases by 
35%, which makes a significant contribution to increasing the mechanical property. The 
parameters obtained from the optimization are 0.247 mm for A, 2.4 mm for B and 0.865 mm for 
C.  
6.3 FEA simulation of Biodegradable Stent in the Blood Vessel 
The total deformation of the optimized model of the biodegradable stent in a blood vessel 
is expected to investigate through a simulation of static analysis. The procedure consists of 
modeling geometry, setting material properties, applying boundary conditions and loads and 
viewing results.  
 
6.3.1 Modelling geometry 
The geometry consists of two parts: blood vessel and stent (Figures 57 and 58). Firstly, the 
CAD models are built in the Pro/Engineering Software. The length of the blood vessel is 29 mm, 
the inner diameter of the blood vessel is 3.4 mm, and the thickness of artery is 0.5 mm [59]. The 
length of the biodegradable stent is 23 mm, the outer diameter of the stent is 3.4 mm, and the 
diameter of the struts is 0.41 mm.  
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Figure 58 CAD model of blood vessel 
 
 
Figure 59 CAD model of a biodegradable stent with blood vessel 
 
Then, the CAD model can be imported into ANSYS Workbench through the connection 
package that is the same import method used in the last section (Figure 59).  
 
Figure 60 Project schematic for static structural analysis 
The geometry in ANSYS Workbench shows in Fig 60.  
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Figure 61 Geometry in ANSYS Workbench 
In the simulation, the concept of contact and target surfaces are used for each contact region 
(Figure 61). One side of the contact region is comprised of “contact” faces, and the other side of 
the region is made of “target” faces. Based on the fact that biodegradable stents expand to and 
support the blood vessel, the “bonded” contact type is selected in this project, which is basically 
linear behavior. 
 
Figure 62 Contact region between blood vessel and biodegradable stents 
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The mesh cells are mixed with hexahedron and tetrahedron cells. Hexahedrons can fill a 
given volume more efficiently than other mesh shapes, and additionally,hexahedron meshes are 
more uniform. But if hexahedron can not sweep a body, it is free meshed with tetrahedral elements. 
There are 21652 nodes and 8817 elements totally in Figure 62.  
 
Figure 63 Mesh modeling 
6.3.2 Material properties 
Material input is under the “Engineering Data” branch, and material assignments are per 
part under the “Geometry” branch. The required structural material properties are young’s modulus 
and Poisson's ratio for linear static structural analyzes (Figure 63). The stent is made of PCL whose 
young modulus is 400 Mpa, and the Poisson ratio is 0.33 [55]. While the Young’ modulus of the 
blood vessel is 0.45 Mpa, and the Poisson ratio is 0.45 [62].  
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Figure 64 Material properties for blood vessel and biodegradable stents 
 
6.3.3 Loading and Boundary conditions 
Pressures can only be applied to surfaces and always at normal to the surface. Positive 
value acts into the surface, and negative value acts outward from the surface. To simulate the 
vasoconstriction, the pressure is applied on internal surface is (P1) -1.2e-002 Mpa (or 90 mm Hg), 
which is the average blood pressure in the human body (Figure 64). 
 
Figure 65 Pressure on the blood vessel 
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The fixed support constraints all degrees of freedom on vertex, edge, or surface, which 
prevents translations and rotations in X, Y and Z. The fixed supports are applied on the both sides 
of a blood vessel (Figure 65).  
 
Figure 66 Fixed support on the both sides of blood vessel 
 
6.3.4 Results 
The solution obtained from the FEA estimates the exact natural solution (Figure 66).  
 
 
Figure 67 The total deformation of biodegradable stents 
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The blood vessel pressure is 1.2e-002 Mpa, which makes the biodegradable stent in the 
region of elastic deformation. Radial deformation can be observed in the stents as a result of the 
radially compressive forces exerted by the artery. The rigidity of biodegradable stents can resist 
the elastic recoil of the vessel wall, which can be calculated by ∆D/D0: 0.24558/3.4=7.22% while 
the elastic recoil of metallic stents is from 3.7% to 12.8% with the compressive pressures between 
0.7 to 20 atm [63].  The result shows that the rigidity of biodegradable stents is still a little weaker 
than metallic stents.  
6.4 Conclusions 
The total deformation of biodegradable stents in blood vessel shows that the rigidity of 
biodegradable stents is still a little weaker than metallic stents. The maximum stress happened on 
the apex of the stent. A finite element analysis similar to the one herewith proposed could help in 
designing new structure of stents or analyzing actual stents to ensure enough mechanical property. 
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CHAPTER 7 Conclusions and Future work 
 
7.1 Conclusions 
This thesis presented a study toward fabrication and optimal design of biodegradable stents 
for aneurysms treatment. The study focused on developing methods to fabricate the biodegradable 
stents and optimizing the structure of biodegradable stents with an aim to obtain a minimum radial 
deformation in the blood vessel. The major findings of this research are summarized as follows. 
1. The technique of dispensing-based rapid prototyping (DBRP) allowing more accurate control 
over the scaffold microstructure is promising to facilitate the fabrication of stents as designed. 
2. The radial deformation of the biodegradable stent can be characterized by an precise 
compression test system. The biodegradable stents with highest radial stiffness in nine groups 
can be obtained by comparing the forces required to compress stents radially from 10% to 
40%. 
3. The parametric 3D model of biodegradable stents can be built by Pro/Engineer, and the 
simulation of actual compression test can be performed by a static structural analysis through 
ANSYS Workbench. The comparison results between simulation and actual compression test 
show that the finite element model of biodegradable stents is acceptable within the range of 
around 20% radial deformation.  
4. The results of optimization of biodegradable stents present that the total deformation can be 
decreased by 35.82% (from 0.589 mm to 0.378 mm) by modifying the parameters of the 
geometry, which makes a significant contribution to increasing the radial stiffness of 
biodegradable stents.  
5. The total deformation of optimized biodegradable stents in the blood vessel is 0.25 mm in the 
simulation, and the rigidity of biodegradable stents is 7.22%, which can support the blood 
vessel wall. Although the result still shows that the rigidity of biodegradable stents is weaker 
than metallic stents, the finite element analysis could help in designing new stents or analyzing 
actual stents to ensure enough mechanical property. 
7.2 Future Work 
Several future endeavors could potentially improve upon this thesis work. 
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First, the finite element model of biodegradable stents in this thesis is linear, while a more 
accurate model for predicting the force VS deformation in the large deformation region is nonlinear, 
which can be improved with a more precise acquisition of the nonlinear plastic material properties 
and structure modelling. 
 
Second, it is important to model the degradation and time-dependent behavior of 
biodegradable stents, as the mechanical properties of biodegradable stents are highly dependent 
on the process of degradation in the human body. It is a challenge to design a biodegradable stent 
providing structural support for an appropriate time to facilitate the blood vessel healing.  
 
Finally, with an aim of verifying the deformation of biodegradable stents in the blood 
vessel in the simulation, the data of the deformation of the biodegradable stents in vivo test is 
needed.  
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